Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.20 USD
+0.01 (0.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.19 -0.01 (-0.83%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.28 | 0.00% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 18.92%. Look out for ACRS's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting a year-over-year increase of 33.33%.
Earnings History
Price & Consensus
Zacks News for ACRS
Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services